WallStSmart
MENS

Jyong Biotech Ltd. Ordinary Shares

NASDAQ: MENS · HEALTHCARE · BIOTECHNOLOGY

$1.77
+0.57% today

Updated 2026-11-16

Market cap
$140.65M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.06
Dividend yield
—
52W range
$1 – $41
Volume
0.0M

WallStSmart proprietary scores

17
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C
5.0
Quality
C+
3.5
Profitability
D
5.0
Valuation
C+
5/9
Piotroski F-Score
Moderate
-4.1
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →253 stocks currently score above 75

Price targets

Analyst target
—
—
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—

Price chart

Stock snapshot

Strengths
+ Debt/equity -0.74x — low leverage
Risks
- Altman Z -4.07 — distress zone
- Thin margins at 0.00%

Key financials

Revenue Net Income Free Cash Flow
Metric2022202320242025TTM
Revenue$0.00$0.00$0.00$0.00—
Net income$-6.63M$-4.40M$-3.02M$-4.67M$-3.42M
EPS————$-0.06
Free cash flow$-3.22M$-2.60M$-3.62M$-3.04M—
Profit margin—————

Peer comparison

CompanyMkt CapScoreGrowthProfitValueQualityMoSRating
MENS$140.65M174.33.55.05.0—Avoid
LLY$1.27T749.310.05.06.0—Strong Buy
JNJ$682.52B544.78.53.75.5—Buy
ABBV$520.47B776.79.04.05.0-87.62%Strong Buy
UNH$363.01B626.76.04.75.5-24.67%Buy
MRK$362.27B423.36.52.05.0-73.98%Hold

Smart narrative

Jyong Biotech Ltd. Ordinary Shares trades at $1.77. Our Smart Value Score of 17/100 indicates the stock is weak. The company scores 5/9 on the Piotroski F-Score. With an Altman Z-Score of -4.07, it sits in the distress.

Frequently asked questions

What is Jyong Biotech Ltd. Ordinary Shares's stock price?

Jyong Biotech Ltd. Ordinary Shares (MENS) trades at $1.77.

Is Jyong Biotech Ltd. Ordinary Shares overvalued?

Jyong Biotech Ltd. Ordinary Shares carries a Smart Value Score of 17/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.

Altman Z-Score?

Jyong Biotech Ltd. Ordinary Shares's Altman Z-Score is -4.07, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.

Company info

SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD

Quick metrics

P/S ratio—
ROE—
Beta—
50D MA$2.03
200D MA$2.12
Shares out0.07B
Float0.03B
Short ratio—
Avg volume0.0M

Performance

1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—